New partner appointment at Inspicos

Ed Farrington appointed as partner

We proudly announce that European Patent Attorney Ed Farrington is now a shareholder and partner at Inspicos P/S. Ed joined Inspicos as an associate in 2010. Ed specializes in opposition and appeal proceedings at the European Patent Office, and regularly represents clients at oral...

New opportunities in Europe for generics and biosimilar companies

Ulla Klinge reports. An SPC (Supplementary Protection Certificate) is a right issued on the basis of a patent and a marketing authorisation for a drug,and which extends the period of protection for the patented drug for up to 5 years. Until now the holder...

Inspicos has been named Firm of the Year 2019 – having also won the prestigious award in 2018

The back-to-back success marks the third time that Inspicos has been named Firm of the Year in the category Denmark Patent Prosecution by Managing Intellectual Property (MIP). The awards for Europe, Middle East and Africa were presented at a gala ceremony in London on...

EPO Appeal Board exercises its judicial independence

The below article tells the story of how the Administrative Council of the EPO, following political pressure from the EU Commission adopted a rule change in 2017 which in subsequent proceedings pertaining to the EPO’s refusal of a European patent application was held to...

EPO Enlarged Board confirms old disclaimer practice

Jakob Pade Frederiksen reports. The EPO’s Enlarged Board of Appeal (EBA) recently issued its long-awaited decision G 1/16 relating to undisclosed disclaimers. The decision lays down under which circumstances the introduction during prosecution of a patent application before the EPO of a disclaimer not...